STK4 and thyroid gland carcinoma: Altogether, findings obtained in our study indicated that circRNA_0057209 can potentially weaken the miR-183 binding ability to STK4 and activate the Hippo pathway, thus inhibiting the malignant development of thyroid cancer (Figure 9).